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Abstract Two triple cysteine mutants containing Cys-less N- or 
C-terminal halves and the Cys-less GLUT1 were generated by 
site-directed mutagenesis. Following expression in Xenopus 
oocytes, the intrinsic transport activities of the multiple cysteine 
mutants were slightly decreased when either the cysteine residues 
of the C-terminal half or all six residues were changed; substitu- 
tion of serine for cysteine residues located at the N-terminal half 
was without consequence for the catalytic activity. The exofacial 
iigand ethylidene glucose inhibited 2-deoxy-D-glucose uptake of 
wild-type and Cys-less GLUTl-expressing Xenopus oocytes with 
comparable half-saturation constants (11.5 and 13.2 mM). How- 
ever, each of the multiple cysteine mutants exhibited an increase 
in affinity for the endofacial inhibitor cytochalasin B, with the 
greatest effect being observed for the Cys-less construct (decrease 
in Ki by the factor 5-6). 
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1. Introduction 
The family of glucose transporters that mediates facilitative 
diffusion contains six members, which have been isolated, 
cloned and sequenced. These GLUT1 GLUT5 and GLUT7 
share an almost identical topological organization with 12 
transmembrane ~-helices and a 42-65% amino acid identity 
exists between GLUT I  compared with GLUTs 2-5 [1,2]. De- 
rived from the nucleotide sequence GLUT1 is known to possess 
six cysteine residues. Several reviews [3-5] have addressed the 
role of cysteine residues in glucose transport and transporter 
conformation. As proposed by Hebert and Carruthers [6], cys- 
teine residues may be involved in oligomerization or may be 
important for stabilization of a local tertiary structure by disul- 
fide bonds. Sulfhydryl reagents are known to inhibit glucose 
transport, probably by impairment of the interconversion of 
transporter conformation. Our previous results have demon- 
strated that after individual replacement of each single cysteine 
the glucose transport is not diminished [7]. Therefore, individ- 
ual cysteine residues, if involved in oligomerization or intramo- 
lecular stabilization by a single disulfide bond, do not seem to 
be essential for the catalytic activity per se. 
In order to further characterize the role of cysteine residues 
in transport function, we constructed two tripel mutants with 
Cys-less halves (C133S-C201G-C07S and C347S-C421S- 
C429S) as well as a six-fold mutant, i.e. the Cys-less GLUT1. 
Using the Xenopus oocyte expression system, the transport 
activities of these mutants were determined and the uptake 
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rates normalized to the relative plasma membrane contents in 
order to calculate the intrinsic transport activities. Further- 
more, the affinities of both the exofacial ligand ethylidene glu- 
cose and the endofacial transport inhibitor cytochalasin B to 
the multiple cysteine mutants were calculated and compared 
with wild-type GLUT1. 
2. Materials and methods 
2.1. Engineering the triple and and six-fold cysteine mutations 
A 2.4-kb fragment, derived from pSPGT [8], was subcloned into the 
expression vector pSP64T [9] and site-directed mutagenesis performed 
according to the procedure of Deng and Nickoloff[10] using a Clontech 
kit (Clontech Laboratories, Palo Alto, CA). Using the mutated C207S 
GLUTI, the tripel mutant (N-terminal half: C133S-C201G-C207S) was 
constructed. In the same manner, derived from the C347S mutant he 
other tripel cysteine mutant (C-terminal half: C347-C421 S-C429S) was 
created. The Cys-less GLUT1 was generated using the StuI restriction 
site in the middle of the GLUTI cDNA. The resulting changes of the 
mutagenic oligonucleotides and the amino acids are as follows: 
Amino acid no. Nucleotide change Amino acid change 
C133 5' TGC 3' --4 5" AGC 3' C --~ S 
C201 5' TGC 3' ~ 5' GGC 3' C ~ G 
C207 5' TGC 3' ~ 5' AGT 3" C -4 S 
C347 5' TGC 3' ~ 5' AGT 3' C ~ S 
C421 5' TGC 3' --4 5' AGC 3' C --4 S 
C429 5' TGT 3' --+ 5' TCT 3' C --~ S 
Mutagenesis was confirmed by DNA sequence analysis. After in 
vitro transcription, proof of full-length cRNA and quantitation were 
performed as described previously [11]. The final concentration of all 
cRNA preparations was adjusted to 0.5 mg/ml by counting the incorpo- 
rated [35S]UTP and by comparison of the wild-type and mutant cRNAs 
on a denaturing agarose gel, also including 28S and 18S rRNA as 
standards (Pharmacia, Freiburg, Germany). 
2.2. Transport measurements 
Collection, defolliculation and culture of Xenopus oocytes were car- 
ried out routinely as described previously [13]. Three days after micro- 
injection of the respective cRNAs, tritium-labeled 2-deoxy-D-glucose 
(50/.tM, 1 ,uC/0.5 ml) uptake was conducted for comparison of hexose 
transport between wild-type and mutant GLUTl-expressing oocytes. 
In brief, after 30 min incubation of oocytes in 0.5 ml of modified Barth's 
solution (MBS) containing tritium-labeled 2-deoxy-D-glucose the 
oocytes were washed 3 × with ice-cold MBS containing 0.1 mM phlo- 
retin, then dissolved in 1% SDS before the radioactivity was deter- 
mined. 
2.3. Determination of the relative GL UT1 content in plasma membrane 
fractions 
In order to isolate plasma membranes, ingle oocytes (routinely 100 
of each group) were triturated in MBS by use of an adjustable 10-/21 
Eppendorf pipette. For dot-blot analyses, these membrane prepara- 
tions were further treated as described previously [13]. A rabbit antise- 
rum (1:250 dilution) raised against a synthetic peptide corresponding 
to the C-terminal 15 residues of human GLUT 1 (F350; a kind gift from 
Dr. M. Mueckler, Washington Unversity, St Louis, MO) and ~25I- 
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labeled goat anti-rabbit IgG secondary antibody (NEN; specific activity 
6.8 Ci/g) were used for detection. The glucose transporter proteins in 
plasma membrane fractions were compared with a purified glucose 
transporter (a kind gift from Dr. G. Lienhard, Dartmouth Medical 
School, Hanover, NH). After cutting the respective areas, the radioac- 
tivity was determined in a gamma counter (Cobra Auto-Gamma, Pack- 
ard). 
The mutant oligonucleotides were from Molbiol (Berlin, Germany); 
the radiolabeled glucose analogue (2-deoxy-I>[2,6-3H] glucose) from 
Amersham-Buchler (B aunschweig, Germany). The Sequenase version 
2 DNA sequencing kit was from USB (Cleveland, OH) and phloretin 
as well as cytochalasin B was purchased from Sigma (Deisenhofen, 
Germany). 4,6-O-Ethylidene-~-D-glucose was from Aldrich (Steinheim, 
Germany). All other substances u ed were of the highest grade. Xenopus 
laevis frogs were obtained from Xenopus Laborzucht (H. K/ihler, Ham- 
burg, Germany). Statistical evaluation was carried out using Student's 
t test for paired values (conducted with Stat View version 4, Abacus 
Concepts); Ultra Fit (Biosoft) was used for curve-fitting of the data 
points and calculating the K~ values. 
3.  Resu l t s  
The GLUT1 glucose transporter contains 6 cysteine residues 
at positions 133, 201 and 207 (N-terminus half) and 347, 421 
and 429 (C-terminus hall). In recent investigations [7,14], single 
cysteine mutants were tested whether any individual residue 
was critical for function. The results indicate that none of the 
cysteine residues were essential for transport activity. There- 
fore, we constructed glucose transporters with Cys-less N- and 
C-terminal halves, and the Cys-less GLUT1 protein. The proce-  
Table 1 
Uptake rates, relative plasma membrane (PM) contents and relative 
intrinsic activities (IA) of multiple cysteine mutants-containing GLUT1 
(A) Uptake and relative PM content 
Mutants Uptake Relative PM content 
(pmol/oocyte × (cpm/20 pg protein) 
30 min) mean _+ S.D. 
mean + S.D. 
Wild-type GLUTI 34.8 + 8.8 8174 + 2000 
Cys-less N-terminal half 31.8 _+ 8.3 7306 + 2094 
Wild-type GLUT1 34.8 + 8.8 9881 + 4424 
Cys-less C-terminal half 26.6 + 8.6 8273 + 2169 
Wild-type GLUT1 28.8 + 12.1 1666 + 71 
Cys-less GLUT 1 27.2 + 8.2 1668 + 663 
(B) Relative initrinsic activity (rIA): % of wild-type uptake % of wild 
type PM content 
Mutants Relative IA Number of inde- 
(arbitrary units) pendent experiments 
mean + S.E. 
Wild-type GLUT1 1 
Cys-less N-terminal half 1.10 + 0.06 3 
Cys-less C-terminal half 0.87 + 0.05 4 
Cys-less GLUT1 0.85 + 0.07 3 
(A) Tritium-labeled 2-deoxy-D-glucose uptake was determined and the 
mean + S.D. of representative experiments are presented comparing 
wild-type GLUT1 with each of the multiple cyteine mutants. The rela- 
tive contents of plasma membrane (PM) GLUT1 protein were calcu- 
lated from radioactivity ofthe ~25I-labeled goat anti-rabbit IgG second- 
ary antibody of Western dot-blots (mean + S.D. of two to four dots) 
counted in a gamma counter. 
(B) Relative intrinsic activities were calculated by normalizing the up- 
take values to the relative PM contents for the wild-type and the mul- 
tiple cysteine mutants of GLUT 1. For comparison the rlA of wild-type 
GLUT1 was set to 1. The values represent the mean _+ S.E. of relative 
intrinsic activities obtained from three to four independent experi- 
ments. 
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Fig. 1. Ethylidene glucose inhibition of 2-deoxy-D-glucose uptake of 
wild-type and Cys-less GLUTl-expressing oocytes. Fractional uptake 
rates (v/vo -- inhibited/non-inhibited uptake rates) from four independ- 
ent experiments comparing wild-type with Cys-less GLUT1 were in- 
cluded in the curve-fitting performed by UltraFit (Biosoft). Except for 
100 mM ethylidene glucose, the % remaining 2-deoxy-D-glucose uptake 
was not statistically different (P > 0.05) at each of the indicated inhib- 
itor concentrations. The best fits of the data points were obtained 
following the equation of single exponential decay with offset and 
weighting using the Marquardt algorithm. 
dure to determine the relative intrinsic transporter activities 
was as follows. (1) The uptake rates of the mutants were related 
to the wild-type transport activity. (2) The relative contents of 
the plasma membrane were determined and expressed as % of 
wild-type. (3) Uptake rates were normalized to the plasma 
membrane expression. Table 1A presents uptake rates and rel- 
ative plasma membrane contents from representative experi- 
ments for each of the multiple cysteine mutants. Data points 
obtained from three to four independent experiments were 
compiled to calculate the relative intrinsic activities for each 
group. A modest decrease in transport activity (Table 1 B) was 
found after changing the three C-terminus cysteine residues 
(P -- 0.035) and upon replacement of all six cysteine residues 
(P = 0.069), whereas the substitution of serine for cysteine res- 
idues at the N-terminal half was without effect. 
Since multiple cysteine residues might be involved in glucose 
transport regulation by oligomerization or stabilization of a 
particular local tertiary structure, we also investigated whether 
the lack of cysteine residues causes changes in 2-deoxy-D-glu- 
cose uptake inhibition by ethylidene glucose (exofacial inhibi- 
tor) or cytochalasin B (endofacial inhibitor). Fig. 1 presents the 
ethylidene glucose inhibition of 2-deoxy-D-glucose uptake (50 
pM) at four inhibitor concentrations. The Ki value obtained for 
the wild-type GLUT1 (approximately 12 mM) was identical 
with that reported by Hashiramoto et al. [15] in CHO cells and 
was similar to those reported in Xenopus oocytes by Mueckler 
et al. (16 mM) [16] and Due et al. (14 mM) [17]. Although the 
fractional uptake rates (inhibited/non-inhibited uptake rates 
calculated from four independent experiments) were slightly 
greater for the Cys-less construct at each inhibitor concentra- 
tion, the inhibition was statistically different (P < 0.05) only at 
the highest ethylidene glucose concentration (100 mM). 
To further characterize the kinetic behavior of the multiple 
cysteine mutants, cytochalasin B was applied as an inward- 
binding glucose transport inhibitor. Including the data points 
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Fig. 2. Cytochalasin B inhibition of 2-deoxy-D-glucose uptake of wild- 
type and Cys-less GLUTl-expressing oocytes. Fractional uptake rates 
(v/vo = inhibited/non-inhibited uptake rates) obtained from three inde- 
pendent experiments comparing wild-type with Cys-less GLUT1 were 
included in the curve-fitting performed by UltraFit (Biosoft). The best 
fits of the data points were obtained following the equation: 
v/vo = rain + (max- min)/(1 + (ICsJdose N) with 'robust' weighting 
using the Marquardt algorithm. 
of three independent experiments, the 2-deoxy-D-glucose up- 
take was found to be inhibited with a half-saturation constant 
of approximately 0.9/tM (Fig. 2). The calculated value was in 
the range (0.5-1.1/zM) reported for GLUT1 after expression 
in Xenopus oocytes [11,17]. The affinity for cytochalasin B, 
however, clearly increased, when all six cysteine residues were 
replaced by serine (K~ values: 0.16 ¢tM of Cys-less vs. 0.89/zM 
of wild-type GLUT1). This effect prompted us to further inves- 
tigate if cysteine residues of a particular half were responsible 
for the lower K~ values, since only the substitution of the C- 
terminal cysteine residues resulted in a decrease of intrinsic 
activity. Upon comparing 2-deoxy-D-glucose uptake inhibition 
between oocytes expressing the Cys-less N- or C-terminal half, 
the affinities for cytochalasin B were rather similar between 
both groups, with a slightly greater inhibitory effect on the 
triple mutant of the C-terminus (Fig. 3). 
4. Discussion 
Recent studies have begun to address the role of cysteine 
residues in catalytic activity and conformation of GLUT1. The 
general importance can be deduced from their potential in- 
volvement in oligomerization, stabilization of local tertiary 
structures and transport inhibition by sulhydryl reagents. Re- 
sults of Wellner et al. [7] that no single cysteine residue is 
essential for the catalytic activity of GLUT1 were confirmed 
very recently by Due et al. [17]. This group also published for 
the first time 3-O-methyl-l>glucose transport rates of a cyste- 
ine-less construct which were slightly greater than those ob- 
served in wild-type GLUTl-expressing oocytes. They con- 
cluded that cysteines are not required for 3-O-methyl-D-glucose 
transport, thus, excluding oligomerization by disulfide-bond 
formation as a prerequesite of maximum catalytic activity. In 
addition, we calculated the relative intrinsic activities by nor- 
malizing the 2-deoxy-D-glucose uptake rates to the relative 
plasma membrane contents of each of the multiple cysteine 
mutants. Substitutions of cysteine residues that are located at 
the C-terminal half or at all six positions lead to a modest 
reduction of catalytic activities (remaining intrinsic activity was 
85-87% of wild-type GLUT1). A great number of experiments 
confirmed that the simultaneous change of the three cysteine 
residues harbored in the N-terminal half was without conse- 
quence to the 2-deoxy-D-glucose uptake rates. However, it can- 
not be excluded that transporter oligomerization i volves ev- 
eral pairs of cysteine residues without functional consequences 
or that multimeric assembly takes place by means different 
from disulfide bonding (e.g. leucine zipper motif) 
Since replacement of cysteine residues could theoretically 
lead to changes in the local tertiary structure resulting in altered 
affinities for transport inhibitors, ethylidene glucose and cyto- 
chalasin B were applied to inhibit 2-deoxy-D-glucose uptake 
either from the exofacial or endofacial side of the plasma mem- 
brane. Consistent with results of Due et al. [17], only minimal 
differences in inhibition of 2-deoxy-D-glucose uptake rates by 
ethylidene glucose could be detected when wild-type and Cys- 
less GLUT1 were compared. As it was known from our previ- 
ous findings [14] that substitution of arginine for cysteine at 
position 421 decreases the affinity of cytochalasin B to GLUTI,  
serine was introduced instead when the six-fold or the triple 
C-terminal half cysteine mutants was created. The increase in 
affinity of the cysteine-less GLUT1 for cytochalasin B lead to 
the speculation that changes in the local tertiary microstructure 
may enhance the accessibility of the protein to the inhibitory 
substrate from the endofacial side of the membrane, but leaving 
unchanged the outward-facing binding site of ethylidene glu- 
cose. Our results failed to give a definite answer as to whether 
cysteine residues of a particular half of the glucose transporter 
preferentially contribute to this effect. It rather seems that 
change of cysteine residues from both opposite halves are in- 
volved in lowering the K~ values of cytochalasin B. We cannot 
explain at this time the discrepancy between our results and 
those obtained by Due et al. [17] who reported a half-saturation 
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Fig. 3. Cytochalasin B inhibition of 2-deoxy-D-glucose uptake of multi- 
ple cysteine mutants containing the Cys-less N-terminus of C-terminus 
halves determined after expression i Xenopus oocytes. Mean fractional 
uptake rates (v/vo = inhibited/non-inhibited uptake rates) calculated 
for each of the indicated inhibitor concentrations from one experiment 
were included in the curve-fitting performed by UltraFit (Biosoft). The 
means at each inhibitor concentration were determined from the uptake 
rates of 15-20 oocytes. The best fits of the data points were obtained 
following the equation: v/vo = min + (max - rnin)/(1 + (ICs0/dose) N) 
with 'robust' weighting using the Marquardt algorithm. 
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constant of cytochalasin B (1.1/tM) for the Cys-less GLUT1 
which is considered not to be different from the value of wild- 
type transporter. Both groups, however, agree in the notion 
that no single cysteine residue is critical for glucose transport 
and, if oligomerization by disulfide bonds takes place in the 
membrane, it does not contribute much, if at all, to the intrinsic 
activity of GLUT1. 
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